Skip to main content
. 2022 Sep 2;13:977485. doi: 10.3389/fimmu.2022.977485

Figure 3.

Figure 3

Inhibition of insulin signaling pathway by inflammatory signaling. Pro-inflammatory cytokines, including IL-1β, IL-6, and TNF, can activate inflammatory signaling pathways through their receptors. Then activated MAPK and NF-κB signaling pathways inhibit insulin signaling by altering the phosphorylation status of IRS-1, and further lead to a reduction of glucose uptake by adipocyte.